Clusterheadaches.com Message Board


    
      
        Clusterheadaches.com Message Board
        (http://www.clusterheadaches.com/cgi-bin/yabb/YaBB.cgi)
      

        Cluster Headache Help and Support >> Medications, Treatments, Therapies >> Poor GSK
        
(Message started by: Maffumatt on Oct 6^th, 2007, 11:38am)

Title: Poor GSK
Post by Maffumatt on Oct 6^th, 2007, 11:38am

I think they have sucked enough blood from us.

http://www.pharmaceutical-business-review.com/research.asp?guid=DMHC2324
Highlights
GSK has executed a number of well-timed lifecycle management strategies that have ensured Imitrex's market leadership. However, Imitrex's impending patent expiry will result in generic sumatriptan flooding the US market in late 2008, and crucial delays to Trexima's launch will signal the end of GSK's dominance of the migraine market.

Title: Re: Poor GSK
Post by DennisM1045 on Oct 6^th, 2007, 11:55am

Nice! I only have to get through three or four more cycles before that happens ;;D

-Dennis-

Title: Re: Poor GSK
Post by BMoneeTheMoneeMan on Oct 6^th, 2007, 2:15pm

Yeah, those poor bastards.

Between the health insurance companies and the pharmaceutical manufacturers, it's a wonder the suicide rate among clusterheads isn't higher.

Title: Re: Poor GSK
Post by totka2 on Oct 6^th, 2007, 2:16pm

The Czech Zentiva pharma co. sells generic Imigran pills (Cinie) on exactly half price here.
Imigran injection's patent expire in august 2008. Hope Zentiva will produce injection too. GSK sucks :P

Title: Re: Poor GSK
Post by Kevin_M on Oct 6^th, 2007, 2:22pm

on 10/06/07 at 11:38:50, Maffumatt wrote:

Imitrex's impending patent expiry will result in generic sumatriptan flooding the US market in late 2008, ...

Good to hear Matt. With some cost-cutting insurance changes having been implemented lately toward brand name, non-generic prescriptions, this should be helpful. About a year it sounds like. I can't begin to assess the amount of money seen on prescriptions over the years that went to GSK and the extra cost to me from this long monopoly.

Title: Re: Poor GSK
Post by vig on Oct 7^th, 2007, 7:31am

Glaxo never once listened to any CH suggestions regarding dosage size or anything else....

we are their ca$h machine...

Title: Re: Poor GSK
Post by Sometimes on Oct 7^th, 2007, 9:04am

I'm honestly very happy I no longer rely on any prescription meds for my ch's, but will be very happy when they're patent expires for those that do!

Title: Re: Poor GSK
Post by assaultme on Oct 7^th, 2007, 6:09pm

I truly don't know if the big drug companies rip us off or not. At something like $80 or more for two lousy Imitrex refills, one might believe that. I read once that bringing a drug like Imitrex to market here in the USA can cost almost as much as it makes the company during it's patent life.

Now , whether this is true...I don't know.
Lately I was prescribed 6 Imitrex refills. Usually they cost me $25 for two refills (2 pack)
I figured it should be $75...right 3X$25=$75

I was surprised to find out because I was prescribed 3 at a time, my insurance got them to me for only $25...same as if I was prescribed only one...yeah!!!

However, it may just be a mistake and I'll find out soon enough.

If it was a mistake, I have no doubt that my insurance co. will demand I repay them...which I will have to.

Good news for people here who consume a ton of Imitrex. Happy for y'all even if you have to wait a year.
Dave